P369: Financial benefits after the implementation of antimicrobial copper in intensive care units (ICUs)

Methods Medical, epidemiological and financial data into two time periods, before and after the implementation of copper (Cu 63% Zn 37%, Low Lead) were recorded and analyzed in a General ICU. The evaluated parameters were: the importance of patients’ admission (Acute Physiology and Chronic Health Evaluation APACHE II and Simplified Acute Physiology Score SAPS), microbial flora’s record in the ICU before and after the implementation of Cu as well as the impact on epidemiological and ICU’s operation financial parameters.